ClinicalTrials.gg
Status unknownNCT04127201Updated Oct 15, 2019

En_Línea. An Online Treatment to Change Lifestyle in Overweight and Obesity

An interventional study of en_línea and Group therapy in Overweight and Obesity, sponsored by University of Barcelona. Status unknown at 1 site in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2019-10-15.

Primary conditionObesityRegistry: OverweightReclassifiedWhy we changed it
Registry
Overweight — the first condition term the registry derived for this study.
ClinicalTrials.gg
Obesity
Why
  1. The study's listed conditions name Obesity, a narrower term within Overweight.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Barcelona · Not applicable, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Oct 2019), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled Dec 2016, registered Oct 2019).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
305
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 390 studies in Obesity with a site in Spain — 95 open to participants now, 134 under way, 45 of them phase 3. Obesity · Spain.

Planned enrollment
98th of 332
305 · median 124
Started
2016
with 9 others
No phase
220 of 390
41 open now
Registered
140th of 390
by date

Among the 390 studies in Obesity with a site in Spain, this one is the 98th largest by planned enrollment of the 332 interventional ones that give a count, is one of 10 that started in 2016, is one of 220 with no phase, and was the 140th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

95 of the 390 studies in Obesity with a site in Spain are open now. Recruiting first, the newest first:

90 more — sign in →

All 95 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 390 studies in Obesity with a site in Spain, or all of them as a file.
02

Study summary

A randomized controlled trial to test the effectiveness of an online weight control program, called en_línea, comparing with a standard group therapy and a control group

Read the detailed description

This is a randomized controlled trial with three intervention arms: en_línea, standard group therapy and control group. To perform this study, 305 adults (18-65 years) with overweight type II (27-29.9 kg/m2) or obesity type I (30-34.9 kg/m2) will be invited to participate. Interventions will last 17 weeks with follow-ups 1, 3, 6 and 12 months after the post-treatment appointment. The primary outcome will be post-treatment weight loss and the maintenance during the follow-ups. Secondary outcomes will be adherence rates, drop outs and quality of life. Participants will be assessed before randomization and they will be sign an inform consent.

03

Conditions studied

  • Overweight
  • Obesity

Browse trials for

Keywords

  • "online therapy"
  • "weight loss control program"
  • Internet
04

In context

Obesity Reclassified

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

This study's planned enrollment of 305 is above the median of 67 across 9,043 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

University of Barcelona is the lead sponsor of 100 studies on the registry; 30 are open to participants now.

Compared within Obesity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Overweight. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Overweight type II or obesity type I. between 27 and 34.9 kg/m2
  2. Age between 18 and 65 years old
  3. Compliance with all evaluation phases.

Exclusion criteria

Exclusion Criteria:

  1. Presence of several physical disease, i.e. diabetes, hypertension, cancer or metabolic disorders
  2. Presence of several psychological problem, i.e. depression, anxiety
  3. Presence of other eating disorders, i.e. anorexia nervosa, bulimia nervosa, binge eating disorders
  4. Use of drugs, i.e. slimming, anovulatory or psychotropic
  5. Pregnancy or planned pregnancy for the next six months
  6. Following another weight control program at the time of selection.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
305 participants (estimated)

Study arms

  • Experimental
    Online intervention, en_línea

    Participants will be provided with a username and a password to acess to a website. en_línea program is an online adaptation of the LEARN program. The five treatment areas are: Lifestyle, Exercise, Attitudes, Relationships and Nutrition. We have designed and developed a website (www.programaenlinea.org) with 17 weekly treatment sessions and an exclusive mobile application for self-recording.

    Behavioral: en_línea

  • Active comparator
    Standard group therapy

    Participants in this arm will received a 10 sessions of standard primary care group therapy. Sessions 1 and 2 will be weekly and sessions from 3 to 10 will be biweekly. Sessions, between 8 and 10 participants, will be conducted by a specialized psychologist and they will last 90 minutes. Treatment areas will be the same as en_línea, beginning with nutrition and exercise and a progressive incorporation of the other topics. Material to work at home and self-recording will be provided in paper.

    Behavioral: Group therapy

  • No intervention
    Control group

    Participants in the control group only will receive a biweekly newsletter by email without feedback. They will be provided with material and instructions to self-record their daily meals and exercise. The newsletter only will content basic information about nutrition and exercise.

Interventions

  • Behavioralen_línea

    This is an online adaptation of the LEARN program. A self-help weight control program developed by Kelly Brownell in 2004.

    Also known as: Web-based weight control program

  • BehavioralGroup therapy

    This is a traditional behavioral weight control program

07

What researchers measure

Primary outcomes

  1. Weight loss

    5%-10% of weight loss respect the initial weight

    Time frame: 4 months

  2. Maintenance of weight loss 1 month follow-up

    Maintenance of weight loss

    Time frame: 1 month follow-up

  3. Maintenance of weight loss 3 months follow-up

    Maintenance of weight loss

    Time frame: 3 months follow-up

  4. Maintenance of weight loss 6 months follow-up

    Maintenance of weight loss

    Time frame: 6 months follow-up

  5. Maintenance of weight loss 12 months follow-up

    Maintenance of weight loss

    Time frame: 12 months follow-up

Secondary outcomes

  1. Adherence

    80% of completed website activities and 80% of self-records

    Time frame: 4 months

  2. Drop out

    Percentage of participants who finish the treatment

    Time frame: 4 months

  3. Quality of life test measures

    Questionnaire of Quality of Life provided by the LEARN program

    Time frame: 4 months

08

Study locations

1 of 1 sites recruiting
  • Unidad de Terapia de Conducta, University of Barcelona
    Barcelona, 08035, Spain
    Recruiting
09

References and documents

Publications

  • Varela C, Saldana C. En_Linea. An online treatment to change lifestyle in overweight and obesity: study protocol for a randomized controlled trial. BMC Public Health. 2019 Nov 21;19(1):1552. doi: 10.1186/s12889-019-7928-1. PubMed 31752815 ↗

Individual participant data

Plan to share: No — Research team have to meet and make a decision about this field

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2016 (actual). Primary completion is estimated for Dec 2020, 48 months after the start.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 48 months is above that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 11, 2019
First posted
Oct 15, 2019
StartActual
Dec 12, 2016
Primary completionEst.
Dec 2020
CompletionEst.
Dec 2020
Last update
Oct 15, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04127201
Responsible party
Carmina Saldaña (PhD, University of Barcelona) — Principal investigator
First posted
Oct 15, 2019
Start date
Dec 12, 2016
Primary completion
Dec 2020 (estimated)
Completion
Dec 2020 (estimated)
Last update
Oct 15, 2019

Study contacts

Carmina Saldaña, PhD
Contact
csaldana@ub.edu
+3493312125

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion